Documented concern based on cited evidence — not a personalized safety check, not medical advice, and not a decision to combine or avoid. That decision belongs with your prescriber.
Low-grade concern — timing, disclosure, or lab context
Low-grade documented concern. Timing, disclosure, or a lab context decides whether it matters for you.
Mechanism and evidence
Ashwagandha raises testosterone in several randomized trials, roughly 15 percent on average. A testosterone rise does not necessarily translate into more DHT while finasteride is suppressing the conversion, and no trial has measured hair outcomes on the combination.
Evidence tier: rct
The tier names the strongest cited study design. Some anchors studied the supplement on its own, or a related drug in the same class — in those pairs the grade rests on that evidence plus established pharmacology, as agreed with our medical reviewer.
What to discuss with your prescriber
- Tell your prescriber you take ashwagandha; the question is whether added androgen pressure belongs in your plan at all.
- No hair data exist for this pair; expect a conversation, not a research answer.